April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals and…
Read More
April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfil our mission: To improve the quality of life of individuals…
April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in multiple sclerosis treatment on March 28, 2017. In this live Q&A, Dr. Enrique Alvarez answers some common questions on…
The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in multiple sclerosis treatment on March 28, 2017. In this live Q&A, Dr. Timothy Vollmer answers some common questions on…
Last night, the FDA approved Ocrelizumab to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by…
The Rocky Mountain MS Center’s MS Young Professionals Network (MSYPN) is starting to grow! The mission of MSYPN is to provide an opportunity for young professionals to support the work…
Social Security has issued important new regulations which will go into effect for applications filed on or after March 27, 2017. These regulations, in most cases, may make it harder…